158 related articles for article (PubMed ID: 25927275)
1. Meta-Analysis of the Relationship between XRCC1-Arg399Gln and Arg280His Polymorphisms and the Risk of Prostate Cancer.
Yan J; Wang X; Tao H; Deng Z; Yang W; Lin F
Sci Rep; 2015 Apr; 5():9905. PubMed ID: 25927275
[TBL] [Abstract][Full Text] [Related]
2. X-ray repair cross-complementing group 1 polymorphisms and hepatocellular carcinoma: a meta-analysis.
Xie T; Wang ZG; Zhang JL; Liu H
World J Gastroenterol; 2012 Aug; 18(31):4207-14. PubMed ID: 22919255
[TBL] [Abstract][Full Text] [Related]
3. XRCC1 Gene Polymorphisms and Breast Cancer Risk: A Systematic Review and Meta- Analysis Study.
Sanjari Moghaddam A; Nazarzadeh M; Sanjari Moghaddam H; Bidel Z; Keramatinia A; Darvish H; Mosavi-Jarrahi A
Asian Pac J Cancer Prev; 2016; 17(S3):323-30. PubMed ID: 27165246
[TBL] [Abstract][Full Text] [Related]
4. Association of X-ray repair cross-complementing group 1 Arg194Trp, Arg399Gln and Arg280His polymorphisms with head and neck cancer susceptibility: a meta-analysis.
Wu W; Liu L; Yin Z; Guan P; Li X; Zhou B
PLoS One; 2014; 9(1):e86798. PubMed ID: 24497981
[TBL] [Abstract][Full Text] [Related]
5. Association between XRCC1 polymorphisms and the risk of cervical cancer: a meta-analysis based on 4895 subjects.
Zeng X; Zhang Y; Yue T; Zhang T; Wang J; Xue Y; An R
Oncotarget; 2017 Jan; 8(2):2249-2260. PubMed ID: 27903984
[TBL] [Abstract][Full Text] [Related]
6. Associations between XRCC1 Arg399Gln, Arg194Trp, and Arg280His polymorphisms and risk of differentiated thyroid carcinoma: a meta-analysis.
Du Y; Han LY; Li DD; Liu H; Gao YH; Sun DJ
Asian Pac J Cancer Prev; 2013; 14(9):5483-7. PubMed ID: 24175846
[TBL] [Abstract][Full Text] [Related]
7. X-ray repair cross-complementing group 1(XRCC1) genetic polymorphisms and thyroid carcinoma risk: a meta-analysis.
Qian K; Liu KJ; Xu F; Chen XY; Chen GN; Yi WJ; Zhou EX; Tang ZH
Asian Pac J Cancer Prev; 2012; 13(12):6385-90. PubMed ID: 23464463
[TBL] [Abstract][Full Text] [Related]
8. XRCC1 Arg399Gln, Arg194Trp and Arg280His polymorphisms in breast cancer risk: a meta-analysis.
Huang Y; Li L; Yu L
Mutagenesis; 2009 Jul; 24(4):331-9. PubMed ID: 19465687
[TBL] [Abstract][Full Text] [Related]
9. Correlation between X-ray cross-complementing group 1 polymorphisms and the onset risk of glioma: A meta-analysis.
Gu X; Sun H; Chang L; Sun R; Yang H; Zhang X; Cong X
Neural Regen Res; 2013 Sep; 8(26):2468-77. PubMed ID: 25206557
[TBL] [Abstract][Full Text] [Related]
10. Association between the XRCC1 polymorphisms and thyroid cancer risk: a meta-analysis from case-control studies.
Wu FF; He XF; Shen HW; Qin GJ
PLoS One; 2014; 9(9):e87764. PubMed ID: 25211472
[TBL] [Abstract][Full Text] [Related]
11. Genetic polymorphisms of XRCC1 and leukemia risk: a meta-analysis of 19 case-control studies.
Zhang H; Liu H; Jiang G
PLoS One; 2013; 8(11):e80687. PubMed ID: 24363792
[TBL] [Abstract][Full Text] [Related]
12. The XRCC1 Arg399Gln genetic polymorphism contributes to hepatocellular carcinoma susceptibility: an updated meta-analysis.
Pan Y; Zhao L; Chen XM; Gu Y; Shen JG; Liu LM
Asian Pac J Cancer Prev; 2013; 14(10):5761-7. PubMed ID: 24289575
[TBL] [Abstract][Full Text] [Related]
13. Arg399Gln substitution in XRCC1 as a prognostic and predictive biomarker for prostate cancer: Evidence from 8662 subjects and a structural analysis.
Noureddini M; Mobasseri N; Karimian M; Behjati M; Nikzad H
J Gene Med; 2018 Oct; 20(10-11):e3053. PubMed ID: 30160806
[TBL] [Abstract][Full Text] [Related]
14. XRCC1 polymorphisms and cancer risk: a meta-analysis of 38 case-control studies.
Hu Z; Ma H; Chen F; Wei Q; Shen H
Cancer Epidemiol Biomarkers Prev; 2005 Jul; 14(7):1810-8. PubMed ID: 16030121
[TBL] [Abstract][Full Text] [Related]
15. Relationship between XRCC1 polymorphisms and susceptibility to prostate cancer in men from Han, Southern China.
Xu Z; Hua LX; Qian LX; Yang J; Wang XR; Zhang W; Wu HF
Asian J Androl; 2007 May; 9(3):331-8. PubMed ID: 17486273
[TBL] [Abstract][Full Text] [Related]
16. XRCC1 and XPD genetic polymorphisms and susceptibility to age-related cataract: a meta-analysis.
Chi XX; Liu YY; Shi SN; Cong Z; Liang YQ; Zhang HJ
Mol Vis; 2015; 21():335-46. PubMed ID: 25873778
[TBL] [Abstract][Full Text] [Related]
17. XRCC1 genetic polymorphism Arg399Gln and hepatocellular carcinoma risk: a meta-analysis.
Liu F; Li B; Wei Y; Yan L; Wen T; Zhao J; Xu M
Liver Int; 2011 Jul; 31(6):802-9. PubMed ID: 21645210
[TBL] [Abstract][Full Text] [Related]
18. Association between the XRCC1 Arg399Gln polymorphism and head and neck cancer susceptibility: a meta-analysis based on case-control studies.
Liu C; Yin Q; Jiao G; Zhou X; Ying M; Gao W; Hu J; Wei L; Wang N; Wang Y
DNA Cell Biol; 2014 Jun; 33(6):378-87. PubMed ID: 24694255
[TBL] [Abstract][Full Text] [Related]
19. Association between the XRCC1 Arg399Gln polymorphism and risk of cervical carcinoma: a meta-analysis.
Liu DY; Liang HC; Xiao XM
Genet Mol Res; 2015 Aug; 14(3):9821-8. PubMed ID: 26345915
[TBL] [Abstract][Full Text] [Related]
20. Meta-analysis demonstrates no association between XRCC1 Arg399Gln polymorphism and bladder cancer risk.
Dong LM; Zhang XY; Teng H; Li MS; Wang P
Genet Mol Res; 2014 Nov; 13(4):9976-85. PubMed ID: 25501209
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
